KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $473,000 | +392.7% | 66,700 | +324.8% | 0.01% | +400.0% |
| Q1 2017 | $96,000 | -92.9% | 15,700 | -93.2% | 0.00% | -97.1% |
| Q4 2016 | $1,345,000 | +287.6% | 229,600 | +208.2% | 0.03% | +100.0% |
| Q1 2016 | $347,000 | +46.4% | 74,500 | +10.4% | 0.02% | -5.6% |
| Q3 2015 | $237,000 | -82.3% | 67,500 | -14.3% | 0.02% | -71.9% |
| Q1 2014 | $1,342,000 | +633.3% | 78,800 | +333.0% | 0.06% | +300.0% |
| Q3 2013 | $183,000 | +123.2% | 18,200 | +64.0% | 0.02% | +14.3% |
| Q2 2013 | $82,000 | – | 11,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $16,990,000 | 16.50% |
| VHCP Management, LLC | 1,000,273 | $12,954,000 | 6.97% |
| Cormorant Asset Management, LP | 1,700,000 | $22,015,000 | 6.39% |
| HARVEY CAPITAL MANAGEMENT INC | 890,500 | $11,531,000 | 4.76% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 859,672 | $11,133,000 | 2.50% |
| Rhenman & Partners Asset Management AB | 400,000 | $5,180,000 | 2.03% |
| SECTORAL ASSET MANAGEMENT INC | 2,758,950 | $35,728,000 | 1.54% |
| NORTHPOINTE CAPITAL LLC | 1,289,711 | $16,701,000 | 1.47% |
| Knoll Capital Management, LLC | 200,000 | $2,592,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,483,260 | $19,208,000 | 1.00% |